Clinical Trials · NCT03823339
A Research Study, Looking at How Xultophy® Works in People With Type 2 Diabetes in Local Clinical Practice in United Arab Emirates
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 300
- Start date
- Jan 2019
- Locations
- 3 sites, United Arab Emirates
- Primary endpoint
- Change in laboratory measured glycosylated haemoglobin A1c (HbA1c)